Skip to main content
. 2017 May 31;9(6):131. doi: 10.3390/v9060131

Table 1.

Studies of somatic L1 activity in cancer genomes. Column three gives the total number of somatic L1 insertions discovered in the total number of tumors assayed; these estimates take validation rates into account when applicable.

Reference Tumor Type Insertions (Tumors) Important Findings
Miki et al. 1992 [52] Colorectal 1
(1)
First genuine somatic L1 activity; L1 insertion in APC might have initiated colorectal cancer (CRC), but somewhat unclear
Iskow et al. 2010 [51] Lung, brain 8, 0
(20, 10)
Introduced high-throughput L1-Seq assay; Established that somatic L1 activity occurs frequently in lung tumors, but not in brain tumors; Suggested that L1s might drive tumorigenesis; Found a hypomethylation signature that distinguishes L1-permissive lung tumors
Lee et al. 2012 [70] Colorectal, prostate, ovarian, brain, blood 178
(43)
Somatic L1 activity only in epithelial tumors, absent from brain and blood; Genes with somatic L1 insertions typically had decreased expression; Compared features of somatic and germline L1s
Solyom et al. 2012 [71] Colorectal 72
(16)
Positive correlation between patient age and number of somatic L1s; Most L1 insertions occurred after tumor initiation
Shukla et al. 2013 [72] Liver 12
(19)
Intronic somatic L1 insertion into a regulatory element increased expression of candidate liver oncogene ST18; Suggested that L1s might be somatically active in normal liver cells
Pitkänen et al. 2014 [73] Colorectal 83
(92)
All L1 insertions originated from one source element on Chromosome 22, in TTC28; These L1 insertions were previously mischaracterized as translocations
Helman et al. 2014 [74] 11 types 695
(976)
Somatic L1 insertion in an exon of the PTEN tumor suppressor gene (TSG); Lung, colorectal, head and neck, and uterine cancers had highest L1 mobilization levels
Tubio et al. 2014 [75] 12 types 2711
(290)
3 transductions make up 24% of somatic L1 activity; A small number of source elements gave rise to most L1 insertions with transductions; Active sources had promoter hypomethylation; Activity of sources fluctuates over the course of tumor evolution
Paterson et al. 2015 [76] Esophageal 5108
(43)
The majority of L1s were discovered by searching for somatic poly(A) insertions, so some probably represent L1-mediated transposition of non-L1 sequence; Identified active source elements using 3 transductions
Rodić et al. 2015 [77] Pancreatic 409
(20)
Inverse correlation between survival and both the number of somatic L1 insertions and ORF1p protein expression; Retrotransposition occurs throughout tumor development, but is discontinuous
Ewing et al. 2015 [78] Colorectal, pancreatic, gastric, testicular 104
(18)
Frequent somatic L1 insertions in precancerous adenomas; Most somatic L1 insertions were clonal; Validated one somatic non-germline L1 insertion in normal colon; Suggested that L1 insertions are occurring in normal colon or very early in tumorigenesis
Doucet-O’Hare et al. 2015 [79] Esophageal 118
(20)
Found somatic L1 insertions in patients with Barrett’s Esophagus (a cancer-predisposing condition) and esophageal cancer; L1 activity seen in patients that did not develop cancer; Suggested that somatic L1 activity could occur in normal or metaplastic cells
Scott et al. 2016 [80] Colorectal 27
(1)
An L1-initiated CRC caused by L1 mutagenesis of APC TSG; Tumor initiated by activity of a hot, population-specific FL-L1 source element, which was hypomethylated and expressed in normal colon tissue; Demonstrated that L1s can evade somatic repression and initiate tumorigenesis
Achanta et al. 2016 [83] Brain 1
(10)
Found one somatic L1 insertion in a secondary glioblastoma; Cannot rule out that this occurred in normal brain because compared to DNA from blood
Carreira et al. 2016 [84] Brain 0
(14)
Could only validate one TPRT-independent somatic L1 insertion and one likely Alu-Alu recombination event; Conclude that L1 retrotransposition does not occur in primary glioblastoma or glioma
Tang et al. 2017 [81] Ovarian; pancreatic 35, 205
(8, 13)
Found one somatic L1 insertion in BRCA1 TSG intron, in an ovarian cancer; Some pancreatic L1 insertions (76) were discovered in an earlier analysis of this same sequencing data [77] and used for methodological validation here